Hints and tips:
...Miels said the company intends to do as much global M&A in 2024 as it did this year....
...One pharma M&A adviser said new entrants would need more than just bigger reductions in body weight to avoid “falling between the cracks of current and next-generation obesity treatments”....
...I’m undecided, but the best writing thrives on risk, after all....
...He said the Point acquisition was an example of “very smart M&A”....
...I view my own stocks and shares Isa as a flexible retirement fund which I’m hoping to leave invested for decades to come....
...Marc Filippino I’m Marc Filippino, and here’s the news you need to start your day....
...JPMorgan has named Alex Bruce as head of Emea M&A for its financial sponsors group, and tapped Nitin Maheshwari as head of Asia-Pacific strategic investors group M&A....
...It: “I’m sorry, I don’t understand.” Consumer editor Claer Barrett investigates how customer service got so bad....
...Here’s what else I’m keeping tabs on today: Super Tuesday: US voters across 15 states and one territory will cast their ballots in the Democratic and Republican primary elections....
...“I’m ready to be the next prime minister,” Pita, 42, declared on Monday, just 12 hours after preliminary results showed his Move Forward party had scored a sweeping victory in Thailand’s general election...
...Its non-tech winners included Apollo Global, Eli Lilly, Airbus and online gambling company Flutter....
...US vetoed a widely supported UN security council resolution calling for an immediate ceasefire on Friday, and Hanegbi said that the duration of the conflict would not “be measured in weeks . . . and I’m...
...Here’s what else I’m keeping tabs on today: Results: Eli Lilly, the maker of weight loss drug Mounjaro, reports this morning alongside KKR, Spotify, GE Healthcare and Hertz....
...Other drugmakers could still “win” the race in the rapidly growing obesity market dominated by Novo Nordisk and Eli Lilly, according to the chief executive of biotech company Zealand Pharma....
...Obesity drugs: Weight-loss treatments are tipped to rake in $80bn a year by 2030, but smaller companies will struggle to break into a market led by Novo Nordisk and Eli Lilly....
...Eli Lilly said yesterday it’s upped its full-year guidance by about $2bn thanks to its diabetes drug, Mounjaro, that’s used for weight loss. Eli Lilly shares hit a record high after the news....
...Robert Armstrong I’m gonna recommend two books. I would like, Katie, I’m gonna pick some narrative books that really changed my point of view....
...His firm M Klein helped broker the legal truce between the PIF and the PGA Tour over the Saudi’s breakaway LIV Golf tournament, which is designed to include a PIF investment in the PGA Tour — a deal that...
...Results: Apple, Eli Lilly, ConocoPhillips, Fox, Starbucks, S&P Global, Moderna, Shopify and Paramount Global will report before the market opens....
...The success of weight loss drugs from Novo Nordisk and Eli Lilly has prompted other invidious comparisons. Roche is therefore acquiring US-based obesity drugs developer Carmot for up to $3.1bn....
...Eli Lilly as well, one of their longtime rivals, is the only other company that’s kind of level pegging in obesity has also been developing these internally....
...Marc Filippino So, Clive, Eli Lilly’s drug is called and I’m . . . I’m gonna try this one. It’s donan . . . don . . . am . . . mab . . . an . . . donan . . . (laughter) Clive Cookson Donanemab....
...“I’m trying to think about the first time I have to come back home, and immediately I shut down and say I’m not coming back,” he said, his voice breaking....
...“We fucked up and I’m sorry we fucked up. I hope you will forgive us,” said Carta boss Henry Ward....
...“I’m still painting and going to parties with friends.”...
International Edition